Dachuang Cao

Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

Michaëla Diamant, Luc Van Gaal, Stephen Stranks et al. · The Lancet · 2010 · 435 citations

Diabetes Management, Insulin Glargine, Insulin Management +9

Growth Hormone plus Childhood Low-Dose Estrogen in Turner's Syndrome

Judith L. Ross, Charmian A. Quigley, Dachuang Cao et al. · New England Journal of Medicine · 2011 · 208 citations · Full text

Growth Hormone Is Effective in Treatment of Short Stature Associated with Short Stature Homeobox-Containing Gene Deficiency: Two-Year Results of a Randomized, Controlled, Multicenter Trial

Werner Blum, Brenda Crowe, Charmian A. Quigley et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 133 citations

Improved treatment satisfaction and weight‐related quality of life with exenatide once weekly or twice daily¹

Jennie H. Best, Kristina S. Boye, R. R. Rubin et al. · Diabetic Medicine · 2009 · 97 citations · Full text

Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week <scp>PRONTO‐T1D</scp> study

Leslie J. Klaff, Dachuang Cao, Mary Anne Dellva et al. · Diabetes Obesity and Metabolism · 2020 · 89 citations · Full text